RESCHEDULED: Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials Posted on February 27, 2020 by Emily Ortman - Event
Women Make Up 72% of Study Participants for FDA-Approved New Drugs in 2019 Posted on February 21, 2020 by Emily Ortman - Blog Post
SWHR Feedback to FDA on Health of Women Strategic Plan Posted on December 23, 2019 by Emily Ortman - Resource
SWHR Submits Comments to FDA on Pregnancy and Lactation Draft Guidance Posted on July 11, 2019 by Megan Ritchey - Blog Post
SWHR Praises FDA Draft Guidance on Lactation Study Design Posted on July 8, 2019 by Melissa Laitner - Resource
SWHR Comments on FDA Draft Guidance on Post-Approval Pregnancy Safety Studies Posted on July 8, 2019 by Emily Ortman - Resource
SWHR Principles Addressing Disparities in Drug Development Posted on February 21, 2019 by Melissa Laitner - Resource
SWHR Engages With FDA on Patient-Focused Drug Development Posted on January 14, 2019 by Emily Ortman - Blog Post
SWHR Encourages Inclusion of Women’s Voices in Patient-Focused Drug Development Posted on December 14, 2018 by Melissa Laitner - Resource
